Oxipit

Automation technology for global medical imaging

27/11/2023

Don't miss the chance to meet some of the nicest people in medical imaging!

Visit Oxipit at RSNA, booth #3965.

Book a meeting via https://bit.ly/3G21Ria

22/11/2023

We are excited to announce our partnership with Blackford - the pioneering strategic radiology AI platform and solutions provider!

This agreement will bring our innovative AI products to Blackford’s enterprise AI platform.

Learn more at: https://bit.ly/3R9LQgr

And don't forget to visit us at RSNA. Book a meeting via: https://bit.ly/3G21Ria

17/11/2023

A year has passed since the CE certification of the first autonomous AI application ChestLink.

Meet us at to learn about current and upcoming ChestLink deployments, as well as clinical validation studies.

Book a meeating at https://bit.ly/3G21Ria

07/11/2023

Exciting announcement!

University Hospitals Birmingham NHS Foundation Trust (UHB) have begun the evaluation of Oxipit’s ChestLink - the first autonomous AI radiology application.

ChestLink can autonomously report on healthy patient chest x-rays, where it is highly confident that the studies do not include any abnormalities. In other words - the patient is healthy beyond any doubt. These studies are removed from the radiologist reporting workflow.

By automating the reporting of normal studies, the application can produce tremendous time savings for the radiology department - enabling clinicians to focus on cases with pathologies.

At UHB ChestLink will undergo a thorough retrospective validation stage, analyzing almost 200,000 previously reported studies. At this stage, the application will indicate what share of studies can be autonomously reported on. This step also helps clinicians to familiarize with the application, as well as to benchmark its performance on real-world clinical data in the UK.

Learn more about ChestLink here: https://bit.ly/40pfaTj

20/10/2023

Aim for a quick and seamless radiology department AI transformation?

Oxipit ChestLink and ChestEye are available on the Sectra's Amplifier Marketplace.

https://bit.ly/3FnOJ6L

19/10/2023

Next week we are travelling to ESCR-ESTI 2023 in Berlin.

Meet us there!

19/10/2023

Leiden University Medical Center (The Netherlands) expands cooperation with Oxipit by deploying our latest product - AI quality assurance tool for CT Pulmonary Embolism (PE).

The deployment was made via the Sectra platform.

A full suite of Oxipit solutions is already working at LUMC, including Quality for CXR and MSK, as well as the first autonomous AI app ChestLink for healthy patient report automation.

Excited to continue this partnership and enable the future of healthcare!

Learn more at: https://bit.ly/3S5kjOn

18/10/2023

More than 5 years ago Oxipit was founded to address the global shortage of radiology specialists.

In 2019 Oxipit launched the ChestEye AI application. Back then it was a class leading CE certified CAD product, with preliminary reports for 75 CXR findings.

Despite best-in-class performance metrics, we saw that AI CAD applications are only the first step in AI radiology transformation. Preliminary reports can only serve as a stepping stone towards more impactful AI in radiology frameworks.

Today both our products - Quality and ChestLink - are examples of leapfrog technology.

Instead of just identifying and localizing findings, they seamlessly integrate into radiology department workflow with a tangible impact - improving diagnostic accuracy (preventing mistakes) and reducing radiologist workload (healthy patient report automation).

PS Yes, Oxipit also offers a CAD application - yet it works best in combination with ChestLink and Quality tools.

16/10/2023

For many radiology departments across NHS England the challenge is twofold.

Healthcare providers need to address the issue of ever-growing reporting backlogs. Yet with shortage of radiologists, and limited ability to meet the daily demand for reporting, these backlogs are growing every day.

Even in retrospective deployment mode (the first step towards automation), ChestLink can safely autonomously report on healthy patient CXR studies with high-confidence. Entering prospective operations, the application can remove no-findings studies from radiologist workload, preventing them from getting into the backlog pile.

Would your radiology department want 100 hours back?

10/10/2023

Are you going to RCR conference later this week?

Meet our team there!

Get a firsthand view on how Oxipit AI products can autonomously produce healthy patient reports, reduce your reporting backlog and prevent diagnostic mistakes.

09/10/2023

Last year ChestLink took the medical imaging world by storm. It became the first CE certified autonomous AI radiology application.

To this day it remains the only medical imaging AI product capable of autonomous performance.

Learn the story behind ChestLink and the dedicated team who made this breakthrough happen.

https://bit.ly/3QakfLV

02/10/2023

What is striking that all tested algorithms showcased very similar performance, with negligible statistical differences.

Oxipit ChestEye performed at 0.86 AUC for airspace disease, 0.97 AUC for pneumothorax and 0.97 AUC for pleural effusion.

Read more: https://bit.ly/48BHgyv

Address

Saulėtekio Alėja 15
Vilnius
10224

Telephone

+37062599148

Website

http://www.oxipit.ai/

Alerts

Be the first to know and let us send you an email when Oxipit posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Oxipit

27/11/2023

22/11/2023

17/11/2023

07/11/2023

20/10/2023

19/10/2023

19/10/2023

18/10/2023

16/10/2023

10/10/2023

09/10/2023

02/10/2023

Address

Telephone

Website

Alerts

Shortcuts

Share

Category